Orphazyme A/S Net Income

Orphazyme A/S (ORPH) currently reports a net income of $-61M as of June 2024. That compares with $-900M in the prior-year period — up 93.2% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Orphazyme A/S's net income history and peer comparisons.

Orphazyme A/S's net income increased from $-900M to $-61M — a 93.2% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orphazyme A/S's net income of $-61M is lower than the Healthcare sector average of $16B. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Orphazyme A/S reported $-61M in net income as of June 2024. That compares with $-900M in the prior-year period — up 93.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-61M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Orphazyme A/S, and consider following ORPH for alerts when major investors trade the stock.